A quantitative study of α-synuclein pathology in fifteen cases of dementia associated with Parkinson disease

Journal of Neural Transmission

Volumn 121, Issue 2, 2014, Pages 171-181

  Armstrong, Richard A ^a   Kotzbauer, Paul T ^b   Perlmutter, Joel S ^b   Campbell, Meghan C ^b   Hurth, Kyle M ^b   Schmidt, Robert E ^b   Cairns, Nigel J ^b  

^a ASTON UNIVERSITY   (United Kingdom)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Synuclein; Lewy bodies (LB); Lewy grains (LG); Lewy neurites (LN); Parkinson disease with dementia (DPD); Principal components analysis (PCA)

Indexed keywords

ALPHA SYNUCLEIN;

AGED; AMYGDALOID NUCLEUS; ARTICLE; BASOLATERAL AMYGDALA; BRAIN NERVE CELL; CELL DENSITY; CELL ENLARGEMENT; CELL NUCLEUS; CELL TRANSFER; CELL VACUOLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA ASSOCIATED WITH PARKINSON DISEASE; DENTATE GYRUS; DENTATE HILUS; ENTORHINAL CORTEX; FEMALE; GLIA CELL; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA2 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; HUMAN; LEWY BODY; LEWY GRAIN; LEWY NEURITE; MALE; MIDDLE FRONTAL GYRUS; PARKINSON DISEASE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; AMYLOID BETA-PEPTIDES; BRAIN; DEMENTIA; DNA-BINDING PROTEINS; FEMALE; HUMANS; LEWY BODIES; LINEAR MODELS; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLES; NEUROGLIA; NEURONS; PARKINSON DISEASE; UBIQUITIN; VACUOLES;

EID: 84893767695     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-013-1084-z     Document Type: Article

References (41)

1. Antal A, Bandini P, Keri S, Bodis-Wollner I (1998) Visuo-cognitive dysfunctions in Parkinson disease. Clin Neurosci 5:147-152
2. Armstrong RA (1996) Correlations between the morphology of diffuse and primitive β-amyloid (Aβ) deposits and the frequency of associated cells in Down's syndrome. Neuropath Appl Neurobiol 22:527-530
3. Armstrong RA (2003) Quantifying the pathology of neurodegenerative disorders: quantitative measurements, sampling strategies and data analysis. Histopathology 42:521-529
4. Armstrong RA (2008) Visual signs and symptoms of Parkinson disease. Clin Exp Optom 91:129-138
5. Armstrong RA, Cairns NJ (2012) Different molecular pathologies result in similar spatial patterns of cellular inclusions in neurodegenerative disease: a comparative study of eight disorders. J Neural Transm 119:1551-1560
6. Armstrong RA, Hilton AC (2011) Statistical analysis in microbiology: statnotes. Wiley Blackwell, Hoboken
7. Armstrong RA, Cairns NJ, Lantos PL (1997) Laminar distribution of cortical Lewy bodies and neurofibrillary tangles in dementia with Lewy bodies. Neurosci Res Commun 21:145-152
8. Armstrong RA, Cairns NJ, Lantos PL (1998) Lewy body and Alzheimer pathology in temporal lobe in dementia with Lewy bodies. Alzheimer Rep 1:159-163
9. Armstrong RA, Lantos PL, Cairns NJ (2001) Spatial correlations between the vacuolation, prion protein deposits, and neurons in the cerebral cortex in sporadic Creutzfeldt-Jakob disease. Neuropathology 21:266-271
10. Armstrong RA, Ironside J, Lantos PL, Cairns NJ (2009) A quantitative study of the pathological changes in the cerebellum of 15 cases of variant Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol 35:36-45
11. Armstrong RA, Ellis W, Hamilton RL, Mackenzie IRA, Hedreen J, Gearing M, Montine T, Vonsattel J-P, Head E, Lieberman AP, Cairns NJ (2010) Neuropathological heterogeneity in frontotemporal lobar degeneration with TDP-43 proteinopathy: a quantitative study of 94 cases using principal components analysis. J Neural Transm 117:227-239
12. Ball M, Braak H, Coleman P, Dickson D, Duyckaerts C, Gambetti P, Hansen L, Hyman B, Jellinger K, Markesbery W, Perl D, Powers J, Price J, Trojanowski JQ, Wisniewski H, Phelps C, Khatchaturian JQ (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 18:S1-S2
13. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259
14. Braak H, Braak E (1998) Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathologic diagnostic criteria. J Neural Transm 105:801-819
15. Braak H, del Tredici K, Rub U, de Vos RAI, Steur ENHJ, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24:197-211
16. Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson disease-related pathology. Cell Tissue Res 318:121-134
17. Braak H, Rub U, Del Tredici K (2005) Cognitive changes in sporadic Parkinson disease - a cliniconeuropathological correlation. Nervenheil 24:129-136
18. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389-404
19. Ding ZT, Wang Y, Jiang YP, Hashizume Y, Yoshida M, Mimuro M, Inagaki T, Iwase T (2006) Characteristics of alpha-synucleinopathy in centenarians. Acta Neuropathol 111:450-458
20. Duyckaerts C, Sazdovitch V, Seilhean D (2010) Update on the pathophysiology of Parkinson disease. Bull L'Acad Nat Med 194:1287-1303
21. Goedert M, Clavaguera F, Tolnay M (2010) The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci 33:317-325
22. Hawkes CH, Del Tredici K, Braak H (2007) Parkinson disease: a dual hit hypothesis. Neuropathol Appl Neurobiol 33:599-614
23. Josephs KA, Whitwell JL, Parisi JE, Knopman DS, Boeve BF, Geda YE, Jack CR, Petersen RC, Dickson DW (2008) Argyrophilic grains: a distinct disease or an additive pathology? Neruobiol Aging 29:566-573
24. Khachaturian ZS (1985) Diagnosis of Alzheimer's disease. Arch Neurol 42:1097-1105
25. Kotzbauer PT, Cairns NJ, Campbell MC, Racette BA, Tabbal SD, Perlmutter JS (2012) Pathological accumulation of α-synuclein and Aβ in Parkinson disease patients with dementia. Arch Neurol 23:1-6
26. Kovacs GG, Milenkovic IJ, Preusser M, Budka H (2008) Nigral burden of alpha-synuclein correlates with striatal dopamine deficit. Move Disord 23:1608-1612
27. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, INce PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen ENH, Ballard C, de Vos RAI, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113-1124
28. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortusa E, Holliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczun A, Kosaka K, Lee VMY, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mijano Y, Molina JA, Mukaetova-Landinska EB, Pasquier F, Perry RH, Schultz JB, Trojanowski JQ, Yamada M (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863-1872
29. Melzer TR, Watts R, MacAskill MR, Pitcher TL, Livingston L, Keenan RJ, Dalrymple-Alford JC, Anderson TJ (2012) Grey matter atrophy in cognitively impaired Parkinson's disease. J Neurol Neurosurg Psychiatry 83:188-194
30. Mirra S, Heyman A, McKeel D, Sumi S, Crain B, Brownlee L, Vogel F, Hughes J, van Belle G, Berg L (1991) The consortium to establish a registry for Alzheimer's disease (CERAD). II. Standardisation of the neuropathological assessment of Alzheimer's disease. Neurology 41:479-486
31. Oinas M, Paetau A, Myllykangas L, Notkola IL, Kalimo H, Polvikoski T (2010) Alpha-synuclein pathology in the spinal cord autonomic nuclei associates with alpha-synuclein pathology in the brain: a population-based Vantaa 85 + study. Acta Neuropathol 119:715-722
32. Rana AQ, Yousuf MS, Naz S, Qa'aty N (2012) Prevalence and relation to dementia to various factors in Parkinson disease. Psychiatry Clin Neurosci 66:64-68
33. Sabbagh MN, Sandhu SS, Farlow MR, Veddeis L, Shell HA, Caviness JN, Connor DJ, Sue L, Adler CH, Beach TG (2009) Correlation of clinical features with argyrophilic grains at autopsy. Alzheimer Dis Assoc Disord 23:229-233
34. Saito Y, Kawashima A, Ruberu NN, Fujiwara H, Koyama S, Sawaki M, Arai T, Nagura H, Yamanouchi H, Hasegawa M, Iwatsubo T, Murayama S (2003) Accumulation of phosphorylated α-synuclein in aging human brain. J Neuropath Exp Neurol 62:644-654
35. Seno H, Kobayashi S, Inagaki T, Yamamori C, Miyaoka T, Horiguchi J, Wada M, Harada T (2000) Parkinson's disease associated with argyrophilic grains clinically resembling progressive supranuclear palsy: an autopsy case. J Neural Sci 178:70-74
36. Snedecor GW, Cochran WG (1980) Statistical Methods. Iowa State University Press, Ames
37. Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M (1998) Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson disease and dementia with Lewy bodies. Neurosci Lett 251:205-208
38. Steiner JA, Angot E, Brunden P (2011) A deadly spread: cellular mechanisms of α-synuclein transfer. Cell Death and Differ 18:1425-1433
39. Tolnay M, Monsch AU, Staehelin HB, Probst A (1999) Argyrophilic grain disease: a disorder distinct from Alzheimer's disease. Pathologe 20:159-168
40. Willis AW, Shootman M, Kung NH, Evanoff B, Perlmutter JS, Racette B (2012) Predictors of survival in Parkinson disease among United States Medicare beneficiaries. Arch Neurol 69:601-607
41. Zhukareva V, Shah K, Uryu K, Braak H, del Tredici K, Sundarraj S, Clark C, Trojanowski JQ, Lee VMY (2002) Biochemical analysis of tau proteins in argyrophilic grain disease, Alzheimer's disease and Pick's disease: a comparative study. Am J Pathol 161:1135-1141